Table 3.
Major lesions’ characteristics and their distribution in different interventional groups
| Rotarex® | Lysis | Rotarex®+lysis | P-value | |
|---|---|---|---|---|
| Native vessel | 68.5% (100/146) | 78.6% (22/28) | 71.4% (20/28) | ns |
| Bypass | 1.4% (2/146) | 3.6% (1/28) | 10.7% (3/28) | R vs R+L* R vs L ns L vs R+L ns |
| Calcification grade | ||||
| Low | 70.6% (103/146) | 78.6% (22/28) | 71.4% (20/28) | ns |
| Moderate–severe | 29.5% (43/146) | 21.4% (6/28) | 28.6% (8/28) | ns |
| Thrombotic burden | ||||
| Low | 32.3% (50/146) | 28.6% (8/28) | 10.7% (3/28) | R vs R+L* |
| Moderate–severe | 65.8% (96/146) | 71.7% (20/28) | 89.3% (25/28) | R vs L ns L vs R+L ns |
| Length of occlusion (cm) | ||||
| >10 | 75.3% (110/146) | 71.4% (20/28) | 85.7% (24/28) | ns |
| <10 | 24.7% (36/146) | 28.6% (8/28) | 14.3% (4/28) | ns |
| Stent | 55.5% (80/146) | 46.4% (13/28) | 42.9% (12/28) | ns |
| PTA | 73.9% (108/146) | 71.4% (20/28) | 78.6% (22/28) | ns |
Note:
*
P<0.05.
Abbreviations: ns, nonsignificant; R, Rotarex®; L, lysis; PTA, percutaneous transluminal angioplasty.